{'fraction_non_alphanumeric': 0.015600624024960999, 'fraction_numerical': 0.0, 'mean_word_length': 5.484848484848484, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Patent Eligibility of Personalized Medicine Technologies

Personalized medicine holds great promise for improving the diagnosis, treatment, and management of cancer. Personalized cancer therapies rely on the use of biomarkers for information valuable to diagnosis or treatment of an individual. The presence of certain biomarkers, for example, may indicate an increased susceptibility to certain forms of cancer. Biomarkers may also be used to optimize patient treatment. With personalized cancer therapy, the levels of biomarkers in a patient can be used to determine how well the patient is responding to a course of treatment, whether